Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-based Chemotherapy
Thierry Lecomte(Université Paris Cité), Pierre Laurent‐Puig(Inserm), David‐Alexandre Trégouët(Inserm), Franck Zinzindohoué(Assistance Publique – Hôpitaux de Paris), Bruno Landi, Jean‐Marc Ferraz(Assistance Publique – Hôpitaux de Paris), Paul‐Henri Cugnenc(Assistance Publique – Hôpitaux de Paris), Raymond Jian, Philippe Beaune, Anne Berger(Assistance Publique – Hôpitaux de Paris), Marie‐Anne Loriot(Inserm)
Cited by 241
Related Papers
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
|Immunity|2013|4.7k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k